Effects of Meditative Movements on Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引:92
|
作者
Zou, Liye [1 ]
Yeung, Albert [2 ]
Li, Chunxiao [3 ]
Wei, Gao-Xia [4 ]
Chen, Kevin W. [5 ]
Kinser, Patricia Anne [6 ]
Chan, Jessie S. M. [7 ]
Ren, Zhanbing [8 ]
机构
[1] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China
[2] Harvard Med Sch, Depress Clin & Res Program, Boston, MA 02114 USA
[3] Educ Univ Hong Kong, Dept Hlth & Phys Educ, Tai Po, Hong Kong, Peoples R China
[4] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100080, Peoples R China
[5] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA
[6] Virginia Commonwealth Univ, Sch Nursing, Dept Family & Community Hlth Nursing, Richmond, VA 23298 USA
[7] Univ Hong Kong, Dept Psychol, Pokfulam, Hong Kong, Peoples R China
[8] Shenzhen Univ, Dept Phys Educ, Shenzhen 518060, Peoples R China
关键词
mindfulness/meditation; depression; exercise; mood disorders; rehabilitation; TAI-CHI; PRENATAL DEPRESSION; HATHA YOGA; INTERVENTION; ANTIDEPRESSANTS; ANXIETY; WOMEN;
D O I
10.3390/jcm7080195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Tai Chi, Qigong, and Yoga are recognized as the most popular complementary approaches for alleviating musculoskeletal pain, improving sleep quality, and reducing blood pressure. The therapeutic effects of these meditative movements for treating major depressive disorder (MDD) is yet to be determined. Therefore, we examined whether meditative movements (Tai Chi, Qigong, and Yoga) are effective for treating MDD. Seven electronic databases (SPORTDiscus, PubMed, PsycINFO, Cochrane Library, Web of Science, CNKI, and Wanfang) were used to search relevant articles. Randomized controlled trials (RCT) using Tai Chi, Qigong or Yoga as intervention for MDD were considered for the meta-analysis (standardized mean difference: SMD). Results: Meta-analysis on 15 fair-to-high quality RCTs showed a significant benefit in favor of meditative movement on depression severity (SMD = -0.56, 95% CI -0.76 to -0.37, p < 0.001, I-2 = 35.76%) and on anxiety severity (SMD = -0.46, 95% CI -0.71 to -0.21, p < 0.001, I-2 = 1.17%). Meditative movement interventions showed significantly improved treatment remission rate (OR = 6.7, 95% CI 2.38 to 18.86, p < 0.001) and response rate (OR = 5.2, 95% CI 1.73 to 15.59, p < 0.001) over passive controls. Conclusions: Emphasizing the therapeutic effects of meditative movements for treating MDD is critical because it may provide a useful alternative to existing mainstream treatments (drug therapy and psychotherapy) for MDD. Given the fact that meditative movements are safe and easily accessible, clinicians may consider recommending meditative movements for symptomatic management in this population.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
    Mocko, Pawel
    Sladowska, Katarzyna
    Kawalec, Pawel
    Babii, Yana
    Pilc, Andrzej
    [J]. BIOMEDICINES, 2023, 11 (10)
  • [32] Effects of supervised exercise on depressive symptoms in hemodialysis patients: A systematic review and meta-analysis of randomized controlled trials
    Shimoda T.
    Matsuzawa R.
    Hoshi K.
    Yoneki K.
    Harada M.
    Watanabe T.
    Matsunaga A.
    [J]. Renal Replacement Therapy, 3 (1)
  • [33] Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
    Jiang, Feiyu
    Li, Hang
    Chen, Yanting
    Lu, Haifeng
    Ni, Jianqiang
    Chen, Gang
    [J]. MEDICINE, 2023, 102 (07) : E32754
  • [34] Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trials
    Lian, Jinrong
    Lin, Zhimin
    Li, Xiang
    Chen, Gang
    Wu, Depei
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 354 : 206 - 215
  • [35] A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
    Thase, Michael E.
    Mahableshwarkar, Atul R.
    Dragheim, Marianne
    Loft, Henrik
    Vieta, Eduard
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 979 - 993
  • [36] Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials
    Guangjian Li
    Xu Wang
    Dihui Ma
    [J]. Clinical Drug Investigation, 2016, 36 : 509 - 517
  • [37] Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials
    Li, Xiao-Mei
    Shi, Zhan-Ming
    Wang, Pei-Jia
    Hu, Hua
    [J]. GENERAL PSYCHIATRY, 2020, 33 (03)
  • [38] Effects of ketamine in electroconvulsive therapy for major depressive disorder:meta-analysis of randomised controlled trials
    Xiao-Mei Li
    Zhan-Ming Shi
    Pei-Jia Wang
    Hua Hu
    [J]. 上海精神医学, 2020, (03) : 127 - 134
  • [39] Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
    Nelson, J. Craig
    Papakostas, George I.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (09): : 980 - 991
  • [40] Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials
    Li, Guangjian
    Wang, Xu
    Ma, Dihui
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (07) : 509 - 517